Jun 04, 2020
Servier Completes the Acquisition of Symphogen
May 08, 2020
FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
Feb 26, 2020
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Dec 04, 2019
Servier Showcases Robust Presence at ASH 2019
Jun 03, 2019
Servier and MBC BioLabs Announce Winner of the 2019 Servier Golden Ticket
May 29, 2019
Servier Showcases Robust Presence at ASCO 2019
May 09, 2019
Servier Cuts Ribbon on New Boston Headquarters
Apr 04, 2019
Servier and Ipsen Join Access Accelerated to Fight Growing NCD Burden
Mar 20, 2019
Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis
Mar 13, 2019
CureMatch and WeHealth By Servier Announce Partnership to Deliver A Digital Decision-Support Platform For Oncologists Worldwide
Nov 20, 2018
FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder
Sep 26, 2018
China's Gliclazide Market 2018-2022: Sales Value of Gliclazide Kept Rising After the Drug Entered China, and Exceeded CNY 200 Million in 2017
Jun 12, 2018
WeHealth by Servier joins forces with Peter Sheehan Diabetes Care Foundation in the fight against diabetes
Feb 14, 2018
ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
Nov 10, 2017
Servier Canada announces the launch of VENIXXA(TM), an over-the-counter oral treatment to relieve signs and symptoms of chronic venous disease and hemorrhoids
Oct 19, 2017
Servier CDMO expands Preparative Chromatography platform at Normandy Site to support market need
Aug 03, 2017
CTI BioPharma Reports Second Quarter 2017 Financial Results
Jun 21, 2017
Servier Canada, Government of Alberta, and the University Hospital Foundation announce the formation of the Servier Alberta Innovation in Health Fund (SAIHF)